Disruptions in Availability of Hemodialysis Bloodlines - Letter to Health Care Providers
March 14, 2025 The U.S. Food and Drug Administration (FDA) is aware that the U.S. is experiencing interruptions in the supply of hemodialysis bloodlines because of recent supplier issues. The disruption in supply of this device is expected to impact …